title: Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonists.
authors.affiliation: Department of Clinical Sciences and Laboratory Medicine, Kansai Medical University, Moriguchi, Japan.
authors.forename: Masamichi
authors.initials: M
authors.lastname: Yoshika
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Komiyama
authors.forename: Midori
authors.initials: M
authors.lastname: Masuda
authors.forename: Toyohiko
authors.initials: T
authors.lastname: Yokoi
authors.forename: Hiroya
authors.initials: H
authors.lastname: Masaki
authors.forename: Hiroe
authors.initials: H
authors.lastname: Ohkura
authors.forename: Hakuo
authors.initials: H
authors.lastname: Takahashi
mesh_terms: D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D002097:C-Reactive Protein / Q000032:analysis / Q000187:drug effects*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011804:Quinolines / Q000494:pharmacology*; D016896:Treatment Outcome
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011804:Quinolines; D002097:C-Reactive Protein; C108475:pitavastatin